Treatment of aromatase (CYP19A1) inhibitor reduces fertility in porcine sperm

被引:5
|
作者
Oh, Jong-Nam [1 ]
Hwang, Jae Yeon [1 ]
Choi, Kwang-Hwan [1 ]
Lee, Chang-Kyu [1 ,2 ]
机构
[1] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul 151921, South Korea
[2] Seoul Natl Univ, Inst Green Bio Sci & Technol, Designed Anim & Transplantat Res Inst, Kangwon Do 232916, South Korea
基金
新加坡国家研究基金会;
关键词
CYP19A1; protein; Fertility; Pig; Sperm; EARLY EMBRYO DEVELOPMENT; IN-VITRO FERTILIZATION; MESSENGER-RNA; CYTOCHROME-P450; AROMATASE; MALE REPRODUCTION; SEMINAL PLASMA; INFERTILE MEN; SWIM-UP; SPERMATOZOA; PERCOLL;
D O I
10.1017/S0967199414000781
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To ascertain whether aromatase (CYP19A1) expression is linked to sperm fertility of pigs, the present study determined the expression of the CYP19A1 gene in porcine sperm and its relationship with fertilization in vitro. First, to investigate its role in fertility, the presence of CYP19A1 of mRNA and protein expression in porcine sperm were confirmed by real-time (RT) or quantitative polymerase chain reaction (q-PCR) and by western blots. The expression levels were determined quantitatively using two sperm groups recovered by a Percoll gradient, which revealed that the sperm group with a low density had a higher penetration rate than that of the high-density group (P < 0.05). However, the expression level of CYP19A1 was not significantly different between the two groups. Secondly, to examine the effect of aromatase activity on fertilization, fresh semen was treated with a steroidal inhibitor, exemestane (50 M for 0.5 h), followed by the dose- and time-dependent viability test. Our results clearly showed that an exemestane treatment effect (P < 0.05) was found for both the sperm-penetration rate and the oocyte cleavage rate. These results indicated that CYP19A1 could be involved in sperm fertility and its expression in sperm plays an important role in fertilization.
引用
收藏
页码:98 / 106
页数:9
相关论文
共 50 条
  • [1] The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?
    Glubb, Dylan M.
    O'Mara, Tracy A.
    Shamsani, Jannah
    Spurdle, Amanda B.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [2] Phosphorylation of human placental aromatase CYP19A1
    Ghosh, Debashis
    Egbuta, Chinaza
    Kanyo, Jean E.
    Lam, TuKiet T.
    BIOCHEMICAL JOURNAL, 2019, 476 : 3313 - 3331
  • [3] Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
    Mao, Jun J.
    Su, H. Irene
    Feng, Rui
    Donelson, Michelle L.
    Aplenc, Richard
    Rebbeck, Timothy R.
    Stanczyk, Frank
    DeMichele, Angela
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [4] Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
    Jun J Mao
    H Irene Su
    Rui Feng
    Michelle L Donelson
    Richard Aplenc
    Timothy R Rebbeck
    Frank Stanczyk
    Angela DeMichele
    Breast Cancer Research, 13
  • [5] Aromatase excess syndrome in a family with upstream deletion of CYP19A1
    Shihara, Daizou
    Miyado, Mami
    Nakabayashi, Kazuhiko
    Shozu, Makio
    Ogata, Tsutomu
    Nagasaki, Keisuke
    Fukami, Maki
    CLINICAL ENDOCRINOLOGY, 2014, 81 (02) : 314 - 316
  • [6] Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene
    Unal, Edip
    Yildirim, Ruken
    Tas, Funda Feryal
    Demir, Vasfiye
    Onay, Huseyin
    Haspolat, Yusuf Kenan
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2018, 10 (04) : 377 - 381
  • [8] A case of Aromatase deficiency due to a novel CYP19A1 mutation
    Gagliardi, Lucia
    Scott, Hamish S.
    Feng, Jinghua
    Torpy, David J.
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [9] Chronic Antipsychotic Treatment Modulates Aromatase (CYP19A1) Expression in the Male Rat Brain
    Katarzyna Bogus
    Artur Pałasz
    Aleksandra Suszka-Świtek
    John J. Worthington
    Marek Krzystanek
    Ryszard Wiaderkiewicz
    Journal of Molecular Neuroscience, 2019, 68 : 311 - 317
  • [10] A case of Aromatase deficiency due to a novel CYP19A1 mutation
    Lucia Gagliardi
    Hamish S Scott
    Jinghua Feng
    David J Torpy
    BMC Endocrine Disorders, 14